Nectar Lifescience Ltd

₹ 33.4 0.00%

24 May - close price

About

Nectar Lifesciences Ltd is primarily engaged in the development, manufacture and marketing of various active pharmaceutical ingredients (APIs) and finished dosage forms.^[1]

Key Points

Product Offerings
The company offers high quality cephalosporin intermediates, APIs and Finished dosage formulations (FDF) to meet diverse requirements of its clients. Its key products include Cefixime, Cefuroxime Axetil, Ceftriaxone Sodium and Menthol & its derivatives. ^[1]

Website BSE NSE

Market Cap ₹ 748 Cr.
Current Price ₹ 33.4
High / Low ₹ 45.7 / 16.5
Stock P/E 150
Book Value ₹ 47.7
Dividend Yield 0.00 %
ROCE 5.98 %
ROE 0.47 %
Face Value ₹ 1.00

Add ratio to table

Edit ratios

Pros

Stock is trading at 0.70 times its book value

Cons

Company has low interest coverage ratio.
The company has delivered a poor sales growth of -9.53% over past five years.
Company has a low return on equity of -1.31% over last 3 years.
Promoters have pledged 100% of their holding.
Promoter holding has decreased over last 3 years: -11.4%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	348.75	384.46	364.57	443.01	476.24	403.03	388.65	344.13	388.81	394.13	397.97	452.17	441.38
	319.51	348.82	337.11	396.43	427.09	361.18	396.05	342.69	369.03	358.59	371.11	409.98	392.87
Operating Profit	29.24	35.64	27.46	46.58	49.15	41.85	-7.40	1.44	19.78	35.54	26.86	42.19	48.51
OPM %	8.38%	9.27%	7.53%	10.51%	10.32%	10.38%	-1.90%	0.42%	5.09%	9.02%	6.75%	9.33%	10.99%
	-24.29	5.15	5.10	0.53	0.52	0.36	10.71	13.24	17.92	0.47	10.61	0.48	1.47
Interest	25.65	25.75	18.01	17.62	17.43	21.37	20.99	17.46	19.66	17.62	20.52	24.84	24.16
Depreciation	15.01	14.28	14.15	14.28	14.26	14.70	14.79	14.78	14.85	15.33	15.31	15.37	14.70
Profit before tax	-35.71	0.76	0.40	15.21	17.98	6.14	-32.47	-17.56	3.19	3.06	1.64	2.46	11.12
Tax %	-14.73%	-171.05%	-367.50%	36.09%	35.15%	35.99%	30.80%	47.10%	-68.03%	40.52%	38.41%	36.18%	94.60%
	-40.96	2.07	1.86	9.73	11.66	3.94	-22.47	-9.29	5.36	1.82	1.02	1.57	0.60
EPS in Rs	-1.83	0.09	0.08	0.43	0.52	0.18	-1.00	-0.41	0.24	0.08	0.05	0.07	0.03
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	1,622	1,634	1,638	1,675	1,635	1,873	2,781	2,360	1,539	1,664	1,522	1,686
	1,332	1,345	1,371	1,436	1,411	1,637	2,517	2,142	1,430	1,506	1,467	1,533
Operating Profit	290	289	267	239	224	236	264	218	109	159	55	153
OPM %	18%	18%	16%	14%	14%	13%	10%	9%	7%	10%	4%	9%
	16	12	20	6	23	6	6	4	-22	11	43	13
Interest	115	138	126	123	117	115	148	126	112	79	79	87
Depreciation	76	84	77	57	62	64	63	61	60	57	59	61
Profit before tax	115	78	85	64	67	63	59	36	-85	34	-41	18
Tax %	25%	21%	22%	15%	18%	17%	19%	16%	14%	26%	45%	73%
	86	62	66	54	55	52	47	30	-73	25	-22	5
EPS in Rs	3.82	2.77	2.95	2.42	2.46	2.33	2.11	1.34	-3.26	1.13	-1.00	0.22
Dividend Payout %	3%	4%	3%	4%	2%	2%	2%	4%	0%	0%	0%	0%

Compounded Sales Growth
10 Years:	0%
5 Years:	-10%
3 Years:	3%
TTM:	11%

Compounded Profit Growth
10 Years:	-22%
5 Years:	-36%
3 Years:	28%
TTM:	108%

Stock Price CAGR
10 Years:	2%
5 Years:	10%
3 Years:	2%
1 Year:	93%

Return on Equity
10 Years:	2%
5 Years:	-1%
3 Years:	-1%
Last Year:	0%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Equity Capital	22	22	22	22	22	22	22	22	22	22	22	22
Reserves	845	905	936	932	984	1,036	1,082	1,112	1,038	1,064	1,042	1,047
	879	858	925	962	878	955	903	779	903	860	754	636
	527	609	628	640	696	710	696	719	423	443	371	486
Total Liabilities	2,274	2,394	2,510	2,557	2,581	2,724	2,704	2,632	2,387	2,390	2,189	2,191
	914	948	934	906	881	852	825	785	772	723	662	821
CWIP	139	122	91	99	102	100	100	115	99	85	78	66
Investments	0	0	1	1	1	1	1	1	1	1	1	1
	1,221	1,324	1,485	1,551	1,597	1,771	1,778	1,732	1,515	1,580	1,449	1,304
Total Assets	2,274	2,394	2,510	2,557	2,581	2,724	2,704	2,632	2,387	2,390	2,189	2,191

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	361	255	144	169	199	65	239	286	21	95	133	225
	-99	-90	-60	-77	-18	-29	-26	-33	-29	17	52	-17
	-282	-161	-61	-89	-204	-40	-201	-252	11	-119	-186	-205
Net Cash Flow	-20	4	23	3	-24	-4	12	1	4	-8	-0	2

Ratios

Standalone Figures in Rs. Crores / View Consolidated

	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	79	84	99	107	112	119	74	61	89	98	67	82
Inventory Days	216	240	253	260	270	226	150	192	185	197	212	215
Days Payable	122	139	146	154	167	142	79	104	108	112	100	127
Cash Conversion Cycle	172	185	207	213	215	203	145	149	166	183	178	170
Working Capital Days	137	152	173	178	186	190	129	149	190	198	204	170
ROCE %	13%	12%	11%	10%	10%	9%	10%	8%	3%	5%	-0%

Shareholding Pattern

Numbers in percentages

	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%
	2.62%	2.46%	1.52%	1.67%	1.49%	16.12%	15.99%	16.07%	16.00%	16.02%	16.12%	16.98%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%
	41.58%	41.74%	42.68%	42.53%	42.72%	28.06%	28.20%	28.12%	28.18%	28.17%	28.05%	27.20%
No. of Shareholders	53,304	55,124	56,073	64,012	63,909	62,940	64,422	62,874	61,582	60,283	60,761	59,946

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%	55.80%
	3.39%	3.38%	2.90%	2.90%	2.62%	1.67%	16.07%	16.98%
	0.83%	0.36%	0.10%	0.00%	0.00%	0.00%	0.00%	0.00%
	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.02%	0.02%
	39.98%	40.46%	41.20%	41.30%	41.58%	42.53%	28.12%	27.20%
No. of Shareholders	36,791	38,709	41,876	40,012	47,394	64,012	62,874	59,946

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Nectar Lifescience Ltd

Nectar Lifescience Ltd

Peer comparison

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flows

Ratios

Shareholding Pattern

Documents

Announcements

Annual reports

Credit ratings